These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 34040696)

  • 1. Hypoxia and its impact on the tumour microenvironment of gastroesophageal cancers.
    King R; Hayes C; Donohoe CL; Dunne MR; Davern M; Donlon NE
    World J Gastrointest Oncol; 2021 May; 13(5):312-331. PubMed ID: 34040696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumour response to hypoxia: understanding the hypoxic tumour microenvironment to improve treatment outcome in solid tumours.
    Bigos KJ; Quiles CG; Lunj S; Smith DJ; Krause M; Troost EG; West CM; Hoskin P; Choudhury A
    Front Oncol; 2024; 14():1331355. PubMed ID: 38352889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ca
    Audero MM; Prevarskaya N; Fiorio Pla A
    Int J Mol Sci; 2022 Jul; 23(13):. PubMed ID: 35806388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cooperation between chemotherapy and immunotherapy in gastroesophageal cancers.
    Davern M; Lysaght J
    Cancer Lett; 2020 Dec; 495():89-99. PubMed ID: 32950619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor Microenvironment and Nitric Oxide: Concepts and Mechanisms.
    Vedenko A; Panara K; Goldstein G; Ramasamy R; Arora H
    Adv Exp Med Biol; 2020; 1277():143-158. PubMed ID: 33119871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxia-modulatory nanomaterials to relieve tumor hypoxic microenvironment and enhance immunotherapy: Where do we stand?
    Yuan CS; Deng ZW; Qin D; Mu YZ; Chen XG; Liu Y
    Acta Biomater; 2021 Apr; 125():1-28. PubMed ID: 33639310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIF expression and the role of hypoxic microenvironments within primary tumours as protective sites driving cancer stem cell renewal and metastatic progression.
    Philip B; Ito K; Moreno-Sánchez R; Ralph SJ
    Carcinogenesis; 2013 Aug; 34(8):1699-707. PubMed ID: 23740838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of tumor microenvironment reprogramming in primary liver cancer chemotherapy resistance.
    Zhao C; Liu S; Gao F; Zou Y; Ren Z; Yu Z
    Front Oncol; 2022; 12():1008902. PubMed ID: 36505831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal stromal cells (MSCs) and colorectal cancer: a troublesome twosome for the anti-tumour immune response?
    O'Malley G; Heijltjes M; Houston AM; Rani S; Ritter T; Egan LJ; Ryan AE
    Oncotarget; 2016 Sep; 7(37):60752-60774. PubMed ID: 27542276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modifying the tumour microenvironment and reverting tumour cells: New strategies for treating malignant tumours.
    Cheng YQ; Wang SB; Liu JH; Jin L; Liu Y; Li CY; Su YR; Liu YR; Sang X; Wan Q; Liu C; Yang L; Wang ZC
    Cell Prolif; 2020 Aug; 53(8):e12865. PubMed ID: 32588948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HER2-Positive Gastroesophageal Cancers Are Associated with a Higher Risk of Brain Metastasis.
    Tincknell G; Naveed A; Nankervis J; Mukhtiar A; Piper AK; Becker TM; Chantrill L; Aghmesheh M; Vine KL; Ranson M; Brungs D
    Cancers (Basel); 2022 Nov; 14(23):. PubMed ID: 36497236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxia induced lactate acidosis modulates tumor microenvironment and lipid reprogramming to sustain the cancer cell survival.
    Singh L; Nair L; Kumar D; Arora MK; Bajaj S; Gadewar M; Mishra SS; Rath SK; Dubey AK; Kaithwas G; Choudhary M; Singh M
    Front Oncol; 2023; 13():1034205. PubMed ID: 36761981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploiting Current Understanding of Hypoxia Mediated Tumour Progression for Nanotherapeutic Development.
    Feng J; Byrne NM; Al Jamal W; Coulter JA
    Cancers (Basel); 2019 Dec; 11(12):. PubMed ID: 31835751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxic stress: obstacles and opportunities for innovative immunotherapy of cancer.
    Chouaib S; Noman MZ; Kosmatopoulos K; Curran MA
    Oncogene; 2017 Jan; 36(4):439-445. PubMed ID: 27345407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The hypoxic tumour microenvironment.
    Petrova V; Annicchiarico-Petruzzelli M; Melino G; Amelio I
    Oncogenesis; 2018 Jan; 7(1):10. PubMed ID: 29362402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overcoming Hypoxia-Mediated Tumor Progression: Combinatorial Approaches Targeting pH Regulation, Angiogenesis and Immune Dysfunction.
    McDonald PC; Chafe SC; Dedhar S
    Front Cell Dev Biol; 2016; 4():27. PubMed ID: 27066484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decursin promotes HIF-1α proteasomal degradation and immune responses in hypoxic tumour microenvironment.
    Ge Y; Yoon SH; Jang H; Jeong JH; Lee YM
    Phytomedicine; 2020 Nov; 78():153318. PubMed ID: 32896707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of hypoxic signalling in metastasis: towards translating knowledge of basic biology into novel anti-tumour strategies.
    Araos J; Sleeman JP; Garvalov BK
    Clin Exp Metastasis; 2018 Oct; 35(7):563-599. PubMed ID: 30171389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Microenvironment of Lung Cancer and Therapeutic Implications.
    Mittal V; El Rayes T; Narula N; McGraw TE; Altorki NK; Barcellos-Hoff MH
    Adv Exp Med Biol; 2016; 890():75-110. PubMed ID: 26703800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The tumour microenvironment links complement system dysregulation and hypoxic signalling.
    Olcina MM; Kim RK; Melemenidis S; Graves EE; Giaccia AJ
    Br J Radiol; 2019 Jan; 92(1093):20180069. PubMed ID: 29544344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.